Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)
Clinical trial NCT03002818 · COMPLETED
Trial details
- NCT number
- NCT03002818
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-01
- Primary completion
- 2018-04-25
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.